Bal Pharma has commenced commercial production of intermediates and Active Pharma Ingredients (API) at its bulk drugs manufacturing unit in Udaipur. The APL products which of scheduled to be manufactured at this Unit were developed by the company’s R&D facility at Bangalore and due to capacity constraints at Bangalore facility it could not become commercially viable till now.
This unit is expected to ease the capacity concerns of API's and intermediates and will cater to the North are Northeastern markets of the country and also overseas markets.
Bal Pharma is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.
